FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 303:1259-1263 November 27, 1980 Number 22 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Although hypophosphatemia is commonly present in diabetics, little is known about its isolated effects on glucose and insulin metabolism. We therefore investigated glucose metabolism in six nondiabetic subjects with chronic hypophosphatemia. When glucose was infused to maintain a constant hyperglycemic level (125 mg per deciliter [6.9 mmol per liter] above basal levels), the glucose infusion rate was 36 per cent less in the hypophosphatemic group than in controls (4.90 +/- 0.34 mg per kilogram of body weight per minute vs. 7.64 +/- 0.37, P < 0.001), although responses to endogenous insulin were similar. When exogenous insulin was infused at a constant rate to maintain an insulin level about 100 microU per milliliter (718 pmol per liter) above basal levels and glucose was infused as necessary to maintain fasting glucose levels, the infusion rate of glucose was 43 per cent lower in the hypophosphatemic group than in controls (3.80 +/- 0.58 mg per kilogram per minute vs. 6.70 +/- 0.33, P < 0.001), although the clearance rate of insulin was similar in both groups. These results indicate that hypophosphatemia is associated with impaired glucose metabolism in both the hyperglycemic and euglycemic states, and that this associated primarily reflects decreased tissue sensitivity to insulin. (N Engl J Med. 1980; 303; 1259-63.).

This article has been cited by other articles:

• Brunelli, S. M., Goldfarb, S. (2007). Hypophosphatemia: Clinical Consequences and Management. J. Am. Soc. Nephrol. 18: 1999-2003 [Abstract] [Full Text]  
• Marz, W., Seelhorst, U., Wellnitz, B., Tiran, B., Obermayer-Pietsch, B., Renner, W., Boehm, B. O., Ritz, E., Hoffmann, M. M. (2007). Alanine to Serine Polymorphism at Position 986 of the Calcium-Sensing Receptor Associated with Coronary Heart Disease, Myocardial Infarction, All-Cause, and Cardiovascular Mortality. J. Clin. Endocrinol. Metab. 92: 2363-2369 [Abstract] [Full Text]  
• Brown, K. A., Dickerson, R. N., Morgan, L. M., Alexander, K. H., Minard, G., Brown, R. O. (2006). A New Graduated Dosing Regimen for Phosphorus Replacement in Patients Receiving Nutrition Support. JPEN J Parenter Enteral Nutr 30: 209-214 [Abstract] [Full Text]  
• Cohen, J., Kogan, A., Sahar, G., Lev, S., Vidne, B., Singer, P. (2004). Hypophosphatemia following open heart surgery: incidence and consequences. Eur. J. Cardiothorac. Surg. 26: 306-310 [Abstract] [Full Text]  
• Xie, Z., Li, H., Liu, L., Kahn, B. B., Najjar, S. M., Shah, W. (2000). Metabolic regulation of Na+/Pi-cotransporter-1 gene expression in H4IIE cells. Am. J. Physiol. Endocrinol. Metab. 278: E648-E655 [Abstract] [Full Text]  
• Sacks, G. S., Walker, J., Dickerson, R. N., Kudsk, K. A., Brown, R. O. (1994). Observations of Hypophosphatemia and Its Management in Nutrition Support. Nutr Clin Pract 9: 105-108 [Abstract]  
• Baker, S. S., Dwyer, E., Queen, P. (1986). Metabolic Derangements in Children Requiring Parenteral Nutrition. JPEN J Parenter Enteral Nutr 10: 279-281 [Abstract]  
• Wilson, H. K., Keuer, S. P., Lea, A. S., Boyd, A. E. III, Eknoyan, G. (1982). Phosphate Therapy in Diabetic Ketoacidosis. Arch Intern Med 142: 517-520 [Abstract]